Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature

Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambrianides, Sakis, Kinnis, Evgenios, Leonidou, Eleni, Pantzaris, Marios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180259/
https://www.ncbi.nlm.nih.gov/pubmed/30323758
http://dx.doi.org/10.1159/000492891
_version_ 1783362165058568192
author Lambrianides, Sakis
Kinnis, Evgenios
Leonidou, Eleni
Pantzaris, Marios
author_facet Lambrianides, Sakis
Kinnis, Evgenios
Leonidou, Eleni
Pantzaris, Marios
author_sort Lambrianides, Sakis
collection PubMed
description Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on case reports that natalizumab could induce or aggravate psoriasis. In this case study, we present a 33-year-old patient who developed plaque psoriasis during natalizumab treatment.
format Online
Article
Text
id pubmed-6180259
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-61802592018-10-15 Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature Lambrianides, Sakis Kinnis, Evgenios Leonidou, Eleni Pantzaris, Marios Case Rep Neurol Case Report Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on case reports that natalizumab could induce or aggravate psoriasis. In this case study, we present a 33-year-old patient who developed plaque psoriasis during natalizumab treatment. S. Karger AG 2018-09-18 /pmc/articles/PMC6180259/ /pubmed/30323758 http://dx.doi.org/10.1159/000492891 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Lambrianides, Sakis
Kinnis, Evgenios
Leonidou, Eleni
Pantzaris, Marios
Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
title Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
title_full Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
title_fullStr Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
title_full_unstemmed Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
title_short Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
title_sort does natalizumab induce or aggravate psoriasis? a case study and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180259/
https://www.ncbi.nlm.nih.gov/pubmed/30323758
http://dx.doi.org/10.1159/000492891
work_keys_str_mv AT lambrianidessakis doesnatalizumabinduceoraggravatepsoriasisacasestudyandreviewoftheliterature
AT kinnisevgenios doesnatalizumabinduceoraggravatepsoriasisacasestudyandreviewoftheliterature
AT leonidoueleni doesnatalizumabinduceoraggravatepsoriasisacasestudyandreviewoftheliterature
AT pantzarismarios doesnatalizumabinduceoraggravatepsoriasisacasestudyandreviewoftheliterature

Ejemplares similares